8-K filing — Eton Pharmaceuticals, Inc. (ETON)
Filed: 2026-09-28 AccNo: 0001437749-26-031281 Size: 183 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Dow Falls Over 100 Points; US Consumer Sentiment Declines In August
Dow falls 0.26% while Nasdaq drops 0.51%. Energy shares rise 1.3%, tech stocks fall 0.6%. US retail sales down 0.6%, consumer sentiment declines.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
Eton Pharmaceuticals announced record Q2 2026 revenue with product sales of $37.6 million, representing 99% year-over-year growth. The company reported GAAP EPS of $0.35 and non-GAAP EPS of $0.43, with EBITDA of $14.1 million. Additionally, Eton expanded its infantile hemangioma franchise by acquiring U.S. rights to ASN-001, a late-stage product candidate targeting moderate infantile hemangiomas, complementing its existing HEMANGEOL product.
Innventure Enters At The Market Offering Agreement With Lucid Capital Markets; May Offer And Sell Common Stock Up To $60M Aggregate Offering Price
-SEC Filing
Innventure shares are trading higher after the company announced a partnership between its AeroFlexx unit and ZXP Technologies to expand industrial liquid packaging technology across various sectors.